ASCO 2015 Report: In noninvasive breast cancer, anastrozole tops tamoxifen for recurrence prevention in postmenopausal women under 60
by Bruce Sylvester: Anastrozole is significantly more effective than tamoxifen in preventing cancer recurrence after lumpectomy and radiation therapy in postmenopausal women, age 60 or younger with DCIS… read more.